DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
1-Year Return
0.48%
This Quarter Return
+15.82%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$214M
AUM Growth
+$8.02M
(+3.9%)
Cap. Flow
-$27.9M
Cap. Flow
% of AUM
-13.04%
Top 10 Holdings %
Top 10 Hldgs %
48%
Holding
93
New
17
Increased
13
Reduced
25
Closed
14
Top Buys
| 1 |
VYNE Therapeutics
VYNE
|
$2.53M |
| 2 |
Indaptus Therapeutics
INDP
|
$2.5M |
| 3 |
Kura Oncology
KURA
|
$2.05M |
| 4 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$1.92M |
| 5 |
Larimar Therapeutics
LRMR
|
$1.67M |
Top Sells
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
$3.97M |
| 2 |
Insulet
PODD
|
$2.82M |
| 3 |
argenx
ARGX
|
$2.67M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$2.32M |
| 5 |
Rigel Pharmaceuticals
RIGL
|
$2.16M |
Sector Composition
| 1 | Healthcare | 86.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Indaptus Therapeutics
INDP
$5.38M
| $2.5M | 1.17% |
+254
| New | +$2.5M |
|
|
BEAT
27
DELISTED
BioTelemetry, Inc.
BEAT
| $2.45M | 1.15% |
54,500
-15,000
| -22% | -$675K |
|
|
28
argenx
ARGX
$45B
| $2.15M | 1.01% |
25,949
-32,181
| -55% | -$2.67M |
|
29
SCYNEXIS
SCYX
$35.4M
| $2.09M | 0.98% |
127,553
-36,137
| -22% | -$593K |
|
|
CSII
30
DELISTED
Cardiovascular Systems, Inc.
CSII
| $1.92M | 0.9% |
+59,200
| New | +$1.92M |
|
31
Wave Life Sciences
WVE
$1.29B
| $1.83M | 0.86% |
47,900
+3,500
| +8% | +$134K |
|
32
Ardelyx
ARDX
$1.57B
| $1.75M | 0.82% |
472,859
+225,000
| +91% | +$833K |
|
|
FOMX
33
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $1.69M | 0.79% |
338,000
+2,500
| +0.7% | +$12.5K |
|
|
34
Larimar Therapeutics
LRMR
$332M
| $1.67M | 0.78% |
+13,615
| New | +$1.67M |
|
35
MacroGenics
MGNX
$126M
| $1.62M | 0.76% |
78,305
-4,800
| -6% | -$99.1K |
|
|
AGTC
36
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $1.56M | 0.73% |
421,000
| – | – |
|
|
IMDZ
37
DELISTED
Immune Design Corp.
IMDZ
| $1.5M | 0.7% |
328,500
| – | – |
|
38
Incyte
INCY
$16.7B
| $1.44M | 0.67% |
21,500
+6,500
| +43% | +$436K |
|
39
Leap Therapeutics
LPTX
$11.8M
| $1.37M | 0.64% |
15,164
-4,836
| -24% | -$435K |
|
|
DRNA
40
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $1.35M | 0.63% |
+110,000
| New | +$1.35M |
|
|
NTUS
41
DELISTED
Natus Medical Inc
NTUS
| $1.31M | 0.61% |
37,900
| – | – |
|
42
ProQR Therapeutics
PRQR
$250M
| $1.25M | 0.59% |
171,351
-59,419
| -26% | -$434K |
|
|
TVRD
43
Tvardi Therapeutics, Inc. Common Stock
TVRD
$281M
| $1.2M | 0.56% |
1,745
-861
| -33% | -$594K |
|
44
Johnson & Johnson
JNJ
$428B
| $1.14M | 0.53% |
9,400
| – | – |
|
45
Cidara Therapeutics
CDTX
$1.64B
| $1.11M | 0.52% |
10,638
+9,481
| +819% | +$986K |
|
46
Minerva Neurosciences
NERV
$16.4M
| $1.08M | 0.51% |
16,359
-5,028
| -24% | -$332K |
|
|
ARQL
47
DELISTED
Arqule Inc
ARQL
| $1.04M | 0.49% |
188,664
-296,320
| -61% | -$1.64M |
|
|
ADXS
48
DELISTED
Advaxis, Inc.
ADXS
| $1.01M | 0.47% |
46,467
| – | – |
|
49
Novavax
NVAX
$1.26B
| $1.01M | 0.47% |
+37,500
| New | +$1.01M |
|
|
OBSV
50
DELISTED
ObsEva SA Ordinary Shares
OBSV
| $984K | 0.46% |
64,977
+58,192
| +858% | +$881K |
|